Back to results
CompletedPhase 2

The Treatment of Depression With Botulinum Type A Toxin

NCT01392963

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Seton Mind Institute: Medical Park Tower

Austin, Texas, United States

View on ClinicalTrials.gov
The Treatment of Depression With Botulinum Type A Toxin — TrialFind